A change in the formulation of tenofovir gel an anti HIV gel developed for vaginal use may make it safer to use in the rectum suggests a study published online some promise in reducing HIV risk in women through vaginal Reformulated anti HIV gel may be safe for use in both vagina rectum
HIV infection risk for women halved by gel study UN and WHO warmly wele results of study on use of vaginal gel before ual intercourse HIV infection risk for women halved by gel study Society
A gel applied by women before and after has reduced the risk of HIV infection by more than so called Caprisa study conducted in 900 women Video India s Aids HIV infections halved by gel treatment FT
Funding discussions dominate Aids conference Aids infection risk for women halved by gel says study Gel breakthrough lifts mood at Aids conference SA keen on speedy roll out of Aids gel Mail Guardian Online